You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 622 PD-L1 is a potential predictive biomarker for response to RM-1929 treatment in recurrent head and neck squamous cell carcinoma patients

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
622 PD-L1 is a potential predictive biomarker for response to RM-1929 treatment in recurrent head and neck squamous cell carcinoma patients

 

Online download statistics by month:

Online download statistics by month: November 2020 to August 2024

AbstractFullPdf
Nov 20209209
Dec 202051015
Jan 2021603
Feb 20211604
Mar 202136010
Apr 20212209
May 202111010
Jun 2021006
Jul 2021004
Aug 2021009
Sep 2021005
Oct 202122022
Nov 20218014
Dec 20211608
Jan 20221600
Feb 20221204
Mar 20221003
Apr 20222003
May 202226012
Jun 2022808
Jul 20221602
Aug 20222206
Sep 20221407
Oct 20222005
Nov 20221803
Dec 2022801
Jan 20232005
Feb 20231801
Mar 20231005
Apr 2023605
May 20231602
Jun 20231803
Jul 2023303
Aug 2023803
Sep 2023600
Oct 20231404
Nov 20231401
Dec 20232801
Jan 20242601
Feb 20241001
Mar 20242003
Apr 2024804
May 20241201
Jun 20244103
Jul 20241802
Aug 20241206
Total7780236